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ABSTRACT 
 
Oxidative stress is a common event in most hepatopathies, leading to 
mitochondrial permeability transition pore (MPTP) formation and further exacerbation of 
both oxidative stress from mitochondrial origin and cell death. Intracellular Ca
2+
 
elevations play a permissive role in these events, but the underlying mechanisms are 
poorly known. We examined in primary cultured rat hepatocytes whether the 
Ca
2+
/calmodulin (CaM)-dependent protein kinase II (CaMKII) signalling pathway is 
involved in this process, by using tert-butyl hydroperoxide (tBOOH) as a pro-oxidizing, 
model compound. tBOOH (500 µM, 15 min) induced MPTP formation, as assessed by 
measuring mitochondrial membrane depolarization as a surrogate marker, and increased 
lipid peroxidation in a clyclosporin A (CsA)-sesitive manner, revealing the involvement 
of MPTPs in tBOOH-induced ROS formation. Intracellular Ca
2+
 sequestration with 
BAPTA/AM, CaM blockage with W7 or trifluoperazine, and CaMKII inhibition with 
KN-62 all fully prevented tBOOH-induced MPTP opening and reduced tBOOH-induced 
lipid peroxidation to a similar extent to CsA, suggesting that Ca
2+
/CaM/CaMKII 
signaling pathway fully mediates MPTP-mediated mitochondrial ROS generation. 
tBOOH induced apoptosis, as shown by flow cytometry of annexin V/propidium iodide, 
mitochondrial release of cytochrome c, activation of caspase-3 and increase in the Bax-to-
Bcl-xL ratio, and the Ca
2+
/CaM/CaMKII signaling antagonists fully prevented these 
effects. Intramitochondrial CaM and CaMKII were partially involved in tBOOH-induced 
MPTP formation, since W7 and KN-62 both attenuated the tBOOH-induced, MPTP-
mediated swelling of isolated mitochondria. We concluded that Ca
2+
/CaM/CaMKII 
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signaling pathway is a key mediator of oxidative stress-induced induced MPTP 
formation, and the subsequent exacerbation of oxidative stress from mitochondrial origin 
and apoptotic cell death. 
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INTRODUCTION 
 
Radical oxygen species (ROS) occurring under oxidative stress (OS) conditions plays 
a pivotal role in a wide variety of pathophysiological conditions (Muriel 2009), by 
oxidizing membrane phospholipids, proteins and nucleic acids (Cochrane 1991). The 
cellular alterations induced by this redox misbalance depend on the intensity and duration 
of the oxidative injury. High levels of OS lead predominantly to dramatic changes in 
plasma membrane permeability, release of cytosolic and mitochondrial components, 
impaired mitochondrial adenosine triphosphate (ATP) production and, finally, necrosis. 
Contrarily, lower levels of OS unable to deplete ATP levels cause apoptosis, since 
apoptosis is an energy-requiring process (Eguchi 1997). 
Opening of mitochondrial permeability transition pores (MPTPs) under OS 
conditions has been implicated as a key, causative event in both manners of cell death. 
MPTP occurs by the dynamic association of a multiprotein complex of constitutive and 
regulatory proteins at the sites where the outer mitochondrial membrane is in contact with 
the inner mitochondrial membrane. The nature of this complex is uncertain, but it may 
involve a number of putative constitutive proteins such as the voltage dependent anion 
channel (VDAC) in the outer membrane, adenine nucleotide translocase (ANT), F0 /F1 ATP 
synthase, and the phosphate carrier (PiC) in the inner membrane, and some regulatory 
proteins, such as cyclophilin D and complement component 1, q subcomponent binding 
protein (C1QBP), localized in the matrix; fom all of them, only cyclophilin D has held up 
to genetic scrutiny as an essential protein involved in MPTP formation (Elrod 2013). MPTP 
opening leads to an abrupt increase in the permeability of the inner mitochondrial 
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membrane to small molecular weight solutes (< 1500 Da); this collapses ion gradients 
across the inner mitochondrial membrane, leading to mitochondrial depolarization, 
uncoupling of oxidative phosphorylation and, eventually, ATP depletion (Jeong 2008; 
Imberti 1993). MPTP onset also causes mitochondrial swelling, with rupture of the 
mitochondrial outer membrane and release of cytochrome c and other pro-apoptotic 
molecules from the inter-membrane space to the cytosol (e.g., apoptosis inducing factor, 
Smac/Diablo). These molecules, together with other cytosolic factors, set off a cascade of 
caspase activity that leads to apoptotic cell death (Jeong 2008). Alternatively, the release of 
these proteins may occur through specific changes in the outer membrane permeability, by 
translocation from cytosol of pro-apoptotic, pore-forming proteins such, as Bax and Bid 
(Korsmeyer 2000). 
Appart from governing cell death, MPTPs aggravates the initial OS that triggers its 
primary onset. This occurs by (a) MPTP-induced loss of cytochrome c, which impairs the 
flow of electrons in the respiratory chain inducing overreduction of the complexes and 
leakage of electrons to the cytosol, (b) reduction of the electron acceptor, NAD
+
, which 
results in ROS emission from the -ketoglutarate dehydrogenase complex, and (c) loss of 
glutathione from the matrix, which decreases the mitochondrial capacity to scavenge ROS 
(Chinopoulos 2006). 
Another major feature of the oxidative injury is the increase in cytosolic, free Ca
2+
 
levels; this activates Ca
2+
-dependent degradative enzymes, such as phospholipases, 
proteases and endonucleases, which play a major role in the onset of cell death (Orrenius 
1992). In addition, cellular Ca
2+
 elevations exacerbates OS-induced cell death (Thor 1984), 
by potentiating the capability of ROS to onset MPTP opening (Byrne 1999). Some 
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hypotheses have been advanced to explain this fact, although any of them have been proved 
conclusively as yet. OS causes release of matrix Ca
2+ that can be taken up back into the 
mitochondria (Ca
2+ cycling); this excessive Ca2+ cycling has been proposed to be 
responsible for MPTP onset (Takeyama 1993). In addition, elevations of mitochondrial 
matrix free Ca
2+ may increase mitochondrial respiration, which is controlled by Ca2+-
regulated mitochondrial dehydrogenases. This latter process may overstimulate 
mitochondrial ROS production, thus triggering MPTP by oxidation of free thiol groups in 
ANT, which increases the affinity of this protein for cyclophilin D to induce MPTP 
generation (Kanno 2004). In addition, OS greatly enhances MPTP sensitivity to Ca
2+
. This 
occurs both by increasing cyclophilin D binding to ANT, a critical step in MPTP formation, 
and by reducing the affinity of the intramitochondrial adenine nucleotide-binding site on 
ANT; the binding of adenine nucleotides to this site inhibits competitively Ca
2+
-dependent 
MPTP formation (Halestrap 2000). Therefore, cellular Ca
2+
 overload occurring under OS 
conditions would represent a vicious circle by which Ca
2+
 and ROS mutually potentiate 
each other to exacerbate ROS formation from mitochondrial origin, which induces further 
Ca
2+
 increments. 
Although there is compelling evidence in the literature that Ca
2+
 is involved in ROS-
induced-MPTP opening in hepatocytes, there is no agreement as yet on the mechanisms 
underlying this effect. A likely candidate to mediate Ca
2+
-dependent mitochondrial damage 
is calmodulin (CaM). This protein binds Ca
2+
, and the complex is involved in a variety of 
cell functions through the activation of CaM-dependent enzymes (Colbran 2004). CaM is 
an ubiquitous protein found mainly in liver cytoplasm, nucleus, and plasma membrane 
(Harper 1980), but mitochondria also contain CaM both on the inner membrane and in the 
matrix space (Itano 1986). The organelle holds several CaM-binding proteins as well, 
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which have been implied as mediators of mitochondrial permeability transition (MPT) and 
cell death. They include the phosphatase calcineurin (Molkentin 2001), the cysteine 
protease calpain (Arrington 2006), and protein quinase Ca
2+
/calmodulin-dependent protein 
kinase II (CaMKII) (Joiner 2012). Therefore, at least conceptually, Ca
2+
 overload occurring 
under OS-conditions may excessively activate these CaM-downstream targets, leading to 
MPTP opening and mitochondrial ROS generation. 
In this work, we addressed this hypothesis by using tert-butyl hydroperoxide 
(tBOOH) as a pro-oxidant compound. tBOOH is a synthetic analogue of short-chain lipid 
hydroperoxides formed endogenously under OS conditions, which has been widely used as 
a model to study the effect of OS on biological systems (Nieminen 1995; Byrne 1999; 
Imberti 1993). Apart from inducing OS directly via reduction into both peroxyl and alkoxyl 
free radicals by both cytochrome P450 and the mitochondrial electron chain (Davies 1989), 
tBOOH promotes OS via ROS-induced MPTP formation and further mitochondrial 
production of ROS. This is supported by the finding that MPTP blockers inhibit the late 
phase of mitochondrial pyridine-nucleotide oxidation and ROS generation following 
tBOOH exposure to isolated hepatocytes (Nieminen 1997). This makes tBOOH a unique 
tool to study the factors regulating OS-dependent MPTP onset, and the further 
hepatocellular death. 
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MATERIAL AND METHODS 
 
Materials. Collagenase type A from Clostridium histolyticum was purchased from Gibco 
(Paisley, UK). Leibovitz-15 (L-15) tissue culture medium, bovine serum albumin (fraction 
V), tBOOH, dimethylsulphoxyde (DMSO), Triton X-100, EGTA, sodium dodecyl sulfate 
(SDS), TEMED, DTT , leupeptin, urethane, PMSF, cyclosporin A (CsA), trifluorperazine 
(TFP), FK-506 (tacrolimus), carbonyl cyanide m-chloro-phenylhydrazone (CCCP) and 
tetramethylrhodamine methyl ester (TMRM) were from Sigma Chemical Co. (St. Louis, 
MO). Cellular lysis buffer, KN-62, W7, mouse anti-CaMKII, and mouse anti rat phospho-
CaMKII were from Cell Signaling Technology (Beverly, MA). BAPTA/AM and Fura-
2/AM were from Molecular Probes (Eugene, Oregon, U.S.A.). Goat anti-mouse IgG 
(#31430), chemiluminescence reagent, and Hyperfilm ECL were from Thermo Fisher 
Scientific Inc. (Waltham, MA). All other chemicals were of reagent grade. 
 
Animals. Adult male Wistar rats weighing 300-350 g were used throughout. Animals were 
maintained on a standard diet and water ad libitum, and housed in a temperature (21º-23º 
C) and humidity (45-50%) controlled room, under a constant 12-hour light, 12-hour dark 
cycle. All animals received humane care, according to the Guide for the Care and Use of 
Laboratory Animals prepared by the National Academy of Sciences and published by the 
NIH (publication 25-28, revised 1996). 
 
Hepatocyte isolation. Hepatocytes were isolated from livers by the collagenase perfusion 
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technique, using a modification of the method of Berry and Friend (Berry 1969). Briefly, 
under urethane anesthesia (5mg/kg body wt, ip), heparin was administered in the inferior 
vena cava (1.50 U/kg of body weight), and a 14G catheter (Abbocath-T, Venisystemtm, 
Abbocath Ireland Ltd., Sligo, Ireland) was introduced in the portal vein. This was followed 
by a 10-min, non-recirculant portal perfusion with a Ca
2+
-free, oxygenated (95% O2/5% 
CO2) Hanks' solution, pH = 7.47-7.50, supplemented with HEPES (3 g/l) and EGTA (0.24 
g/l). The livers were then perfused for a further 5-min period with the same solution 
without EGTA, supplemented with 1 mM MgSO4, 2.5 mM CaCl2 and collagenase type IV 
(430 U/l). Finally, the livers were removed, and the cells isolated by mechanical 
dissociation by gently stirring with a glass stick for 3-4 min. Hepatocytes were further 
purified from non-parenchymal cells by low-speed centrifugation (30xg, 2 min), followed 
by 3 consecutive washings in oxygenated Hanks' solution containing 2.5 mM CaCl2 and 5 
mM Tris. The resulting preparation yielded ~ 400-600x10
6
 hepatocytes per liver, with high 
viability (>90%), as assessed by the trypan blue exclusion test (Baur 1975). 
 
Hepatocyte culture. Isolated hepatocytes were plated in 6-well plastic plates precoated with 
rat tail collagen at least 1 day before preparing the hepatocyte cultures. Ice-cold neutralized 
collagen solution was dispensed onto each dish/well, and the coated dishes/plates were 
placed at 37º C in a humidified incubator for approximately 2 h to allow the matrix material 
to gel, followed by addition of 3 ml of DMEM to each dish/plate and storage in a 
humidified incubator. Hepatocyte suspensions were added to the precoated dishes/plates at 
a density of 2 x 10
6
 cells/ 30mm dishes diluted in DMEM. Cells were allowed to attach for 
2-2.5 h at 37º C in a air humidified atmosphere and 5 % CO2. After attachment, the 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
11 
 
medium was aspirated, and 3 ml of fresh DMEM was added. 
 
Treatments. After 18 h of culture, hepatocytes were incubated with 500 µM tBOOH (or the 
vehicle, DMSO, in controls) for 15 min in a humidified incubator at 37º C, with 5% CO2. 
The effect of the pre-incubation of the hepatocytes with a number of modulators was 
studied. Hepatocytes were pre-incubated with these modulators for 15 min, and then 
exposed to tBOOH for a further 15-min period. The modulators were kept in the incubation 
medium throughout tBOOH exposure. 
 
Evaluation of tBOOH effect on hepatocellular integrity. At the end of the incubation 
period with tBOOH, aliquots of hepatocytes were removed to assess cell viability, leakage 
of the cytosolic enzyme, lactate dehydrogenase (LDH; EC 1.1.1.27), and ATP content. 
Viability of hepatocytes cultured on multiwell plates was assessed by the trypan blue 
exclusion test (Baur 1975). 
Plasma membrane integrity was evaluated by the leakage of the cytosolic enzyme, 
LDH, into the incubation medium. LDH activity was assessed spectrophotometrically 
(Perkin Elmer UV/Vis Spectrometer Lambda2S, berlingen, Germany) by measuring NADH 
consumption at 340 nm, using commercial kits (LDH-P UV AA liq, Wiener Lab., Rosario, 
Argentina). LDH release (activity in the medium) was normalized to total LDH activity in 
the cellular compartment. For this purpose, aliquots of the cellular suspension were treated 
with Triton X-100 (0.1% v/v), followed by centrifugation at 9000xg for 2 min. 
ATP content was measured using the substrate-enzyme system, luciferin-luciferase 
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(Lyman 1967). 
 
Evaluation of tBOOH-induced OS. The magnitude of OS induced by tBOOH was 
evaluated in hepatocytes cultured in precoated dishes by measuring generation of the lipid 
peroxidation product malondialdehyde (MDA), and the oxidized glutathione (GSSG)-to-
total glutathione (GSHt) ratio. 
MDA was measured by reaction with thiobarbituric acid followed by the 
fluorimetrical HPLC detection of the MDA-thiobarbituric acid adduct formed, according to 
the HPLC method of Fukunaga et al. (Fukunaga 1998). A standard curve using 1,1,3,3-
tetramethoxypropane, which is converted mol for mol into MDA, was routinely run. 
Cell contents of GSHt and GSSG were determined by the recycling method of Tietze 
(Tietze 1969), as modified by Griffith (Griffith 1980). 
Protein content in the aliquots of cell suspension used for the assay was measured by 
the method of Lowry et al. (Lowry 1951), using BSA as a standard. 
 
Measurement of cytosolic Ca
2+
 concentration ([Ca
2+
]i). [Ca
2+
]i was assessed using Fura-
2/AM as a probe. For this purpose, 2 x 10
6
 cells were suspended at 37º C in 3 ml of a PBS 
(pH = 7.4) buffer solution containing 3 mM CaCl2, and then supplemented with 1µM Fura-
2/AM. Fluorescence intensity (F) was measured by using alternating excitation 
wavelengths of 340 and 380 nm, and a fluorescence emission wavelength of 510 nm (3 nm 
bandwidth). [Ca
2+
]i was calculated from the 340 nm/380 nm Fura-2/AM fluorescence 
intensity ratio (R), according to the following equation (Grynkiewicz 1985): 
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[Ca
2+
]i = Kd [(R-Rmin)/(Rmax-R)] (F380min/F380max) 
where Kd is the dissociation constant of the complex Fura-2/Ca
2+
 (135 nM), Rmax and Rmin 
are R values measured sequentially by addition of 10g/ml digitonin to the Fura-2-loaded 
cells before and after chelating Ca
2+
 with 5 mM EGTA/Tris solution (pH = 8.7), 
respectively. 
 
Assessment of MPTP formation. MPTP generation was evaluated in primary culture of rat 
hepatocytes by assessing the mitochondrial membrane potential as a surrogate marker, 
using TMRM as a probe (Imberti 1993); TMRM is a membrane-permeable, cationic 
fluorophore that accumulates electrophoretically in mitochondria in proportion to their 
membrane potential (Δψ). For this purpose, hepatocytes in 24-well plates were loaded at 
37º C with 8 µM TMRM in Krebs-Henseleit buffer for 10 min. The supernatant was then 
aspirated to remove the excess of TMRM, and fluorescence intensity was measured using a 
fluorescence multiwell plate reader using excitation and emission filters of 546 and 573 nm, 
respectively. Mitochondrial Δψ was calculated from the 573 nm/546 nm TMRM 
fluorescence intensity ratio (R), according to Scaduto and Grotyohann (Scaduto, Jr. 1999), 
and expressed as the percentage of the change in mitochondrial depolarization, in a scale 
ranging from a basal, non-depolarized condition (control value) to the maximal depolarized 
condition, obtained by adding the respiratory chain uncoupling compound, CCCP (10 µM). 
Additionally, MPT was assessed in isolated mitochondria by monitoring the changes 
in mitochondrial osmotic volume (swelling) secondary to MPTP formation. Swelling was 
monitored by the decrease in apparent absorbance (light-scattering), since the light 
scattered is inversely proportional to the mitochondrial volume (Azzone 1965). For this 
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purpose, the mitochondrial fraction (1 mg protein/ml) was resuspended in 1 ml of swelling 
buffer composed of 5 mM KH2PO4, 200 mM sucrose, 5 mM succinate (for mitochondria 
energization), and 25 mM KCl (pH = 7.4). After a 2-min equilibration period, tBOOH (or 
its vehicle, saline) was added so as reach a final concentration of 500 μM, and swelling was 
monitored by recording the changes in absorbance at 540 nm with a Perkin Elmer Lambda 
2S UV-Vis spectrophotometer computer controlled (Norwalk, USA). 
 
Analysis of protein kinase activation. The activation of CaMKII and mitogen-activated 
protein kinases (MAPKs) of the c-Jun NH2-terminal kinase 1/2 (JNK1/2) and p38
MAPK
 
types were assessed by Western blotting using a antibodies recognizing the activate forms 
of these kinases, which are phosphorylated at Thr
286
, Thr
183
/Tyr185, and Thr
180
/Tyr
182
, 
respectively. 
For this purpose, the content of phosphorylated and total forms of the proteins was 
analyzed by Western blotting of primary hepatocyte cultures. After treatment, hepatocytes 
were washed with cold PBS and resuspended in a cellular lysis buffer containing protease 
inhibitors (leupeptin 25 g/ml and PMSF 0.1 mM). Aliquots containing equivalent total 
protein content were subjected to SDS, 12% polyacrylamide gel electrophoresis. Separated 
proteins were electrotransferred to PVDF membranes, and probed overnight with anti-
phospho-CaMKII (1:2000), anti-phospho-JNK1/2 antibody (1:2000), or anti-phospho-
p38
MAPK
 (1:300) antibodies. Membranes were then stripped, and reproved with an anti total-
CaMKII (1:2000), anti–total JNK1/2 (1:5000), or anti-total p38
MAPK
 (1:500) antibodies. 
After using a goat anti-mouse or a mouse anti-goat IgG secondary antibody (1:5000) 
depending on the primary antibody used, a chemiluminescence reagent, and Hyperfilm 
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ECL, the phospho and total bands of each studied protein were quantified by densitometry 
using the Image J 1.34m software. 
 
Apoptosis analysis. Apoptosis was evaluated by the Annexin V/ propidium iodide (PI) flow 
cytometry assay (Vermes 1995). In addition, the involvement of the mitochondrial 
apoptosis pathway in tBOOH-induced hepatocellular death was studied by assessing 
mitochondrial cytochrome c release into cytosol, the subsequent increase in caspase-3 
activity, and the balance between proapoptotic (Bax) and antiapoptotic (Bcl-xL) 
mitochondrial proteins. 
Annexin V flow cytometry assay. After gently homogenization in the culture medium/PBS 
and harvest (5 min, 400 g), hepatocytes were carefully re-suspended in the appropriate 
buffer at the desired concentration. Apoptotic externalization of phosphatidylserine and cell 
death in hepatocytes was assessed by staining with Annexin V-FITC and PI (Annexin V-
FITC Apoptosis Detection Kit, Sigma Chemical Co, St Louis, MO), respectively, coupled 
to flow cytometric analysis (Cell Sorter BD FACSAria II, Becton, Dickinson and Co, 
Franklin Lakes, NJ), following the manufacturer’s instructions. Detection of green and red 
fluorescence was carried out; green and red fluorescence intensities detected in non stained 
cells were used to set the thresholds for each channel. Annexin V positive cells, irrespective 
of whether they were PI positive or negative cells, were considered to be apoptotic in 
nature, either at an early stage of apoptosis (annexin V positive/PI negative cells) or at an 
late stage of apoptosis (annexin V positive/PI positive cells). Even when necrotic cells all 
share the same features as late stage apoptotic cells in terms of pattern of annexin 
V/propidium iodide staining, necrosis can be ruled out from our results showing conserved 
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ATP cellular content (Table 1). Indeed, for the occurrence of apoptosis, normal levels of 
ATP are necessary, whereas low cellular ATP levels are indicative of necrosis (Eguchi 
1997). 
Immunoblot analysis of pro- and anti-apoptotic proteins. The levels of cytochrome c (in 
cytosol) and of Bax and Bcl-xL (mitochondria), all proteins involved in the apoptosis 
process, was determined by immunoblotting. Cytosolic and mitochondrial fractions were 
prepared by differential centrifugation, as previously described (Kim 2006). Briefly, 
mitochondria-enriched fractions were prepared from hepatocytes that were homogenized in 
sacarose 0.3 M with protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 mg/ml 
leupeptin, and 1 mg/ml aprotinin), and sonicated. Homogenates were centrifuged at 1000xg 
to remove unbroken cells, nuclei, and heavy membranes. Mitochondria enriched fractions 
were then obtained by the centrifugation of supernatant at 6000xg at 4°C for 15 min. Then, 
the supernatant was centrifuged at 45000xg for 1 h to obtain the cytosolic fraction (Ronco 
2004). Proteins were quantified in these fractions according to Lowry et al. (LOWRY 
1951). For immunoblotting, 20 µg of protein were subjected to 12% SDS-PAGE, and 
transferred to Immobilon polyvinylidene difluoride (PVDF) membranes (Perkin Elmer Life 
Sciences, Boston, MA, USA). Membranes were blocked with 5% non-fat milk/0.3% 
Tween/PBS, washed, and incubated overnight at 4 ºC with a specific primary antibody 
against Bax, Bcl-xL, or cytochrome c (1:600, Santa Cruz Biotechnology, Santa Cruz, CA, 
USA). Then, membranes were incubated with the appropriate secondary antibody 
conjugated with horseradish peroxidase (1:5000, Amersham Life Science), and the 
resulting bands were detected by enhanced chemiluminescence (ECL; Amersham 
Pharmacia Biotech). Autoradiographs were obtained by exposing PVDF membranes to 
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Amersham hyperfilmTM ECL (GE Healthcare), and the bands quantified by densitometry 
using the Gel-Pro Analyzer software (Media Cybernetics, Silver Spring, MD). 
 
Assessment of caspase-3 activity. Caspase-3 activity was determined according to the 
manufacturer’s instructions, using an EnzChek caspase-3 assay kit (Molecular Probes, 
Eugene, OR, USA). The tissues were homogenized in lysis buffer (10 mM Tris, 200 mM 
NaCl, 1 mM EDTA, and 0.001% Triton X-100). After differential centrifugation, the 
cytosolic fraction from each sample was mixed with a Z-Asp-Glu-Val-Asp-AMC substrate 
solution. A standard curve of AMC ranging from 0-100 mM was run. A control sample 
without enzyme was used to determine the background fluorescence of the substrate. 
Fluorescence was measured at an excitation wavelength of 360 nm and an emission 
wavelength of 465 nm in a DTX 880 Multimode Detector (Beckman Coulter, Brea, CA, 
USA). 
 
Statistical analysis. Data are expressed as mean  SE. Multiple means were compared with 
one-way ANOVA followed by Tukey´s test for pairwise comparisons, by using a computer 
program (PHARM/PCS, MicroComputer Specialist, Philadelphia). Differences were 
considered significant when the p values were < 0.05. 
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RESULTS 
 
Characterization of tBOOH-induced impairment in hepatocellular integrity, oxidative 
stress generation, changes in ATP content and cytosolic Ca
2+
 elevations. As shown in 
Table 1, tBOOH (500 µM, 15 min) impaired hepatocellular integrity, as indicated by a 38% 
decrease in cell viability, and a 31% increase in the release to the incubation medium of the 
cytosolic enzyme, LDH. Contrarily, ATP content was not affected by the oxidant agent. 
An increase in ROS levels was clearly apparent after tBOOH exposure, as indicated by the 
enhancement of one order of magnitude in the generation of the lipid peroxide 
malondialdehyde (Table 1); this was associated with a decrease in both total (GSH + 
GSSG) glutathione and the GSSG-to-total glutathione ratio. This OS was instrumental in 
increasing dramatically (by 25 times) the cytosolic, free Ca
2+
 concentration. 
 
Effect of intracellular Ca
2+
 sequestration and CaM/CaMKII inhibition on tBOOH-
induced changes in mitochondrial Δψ and lipid peroxidation (LPO). MPTP formation 
induced by tBOOH was assessed by measuring depolarization of mitochondrial Δψ as a 
surrogate parameter, using the mitochondrial-sensitive cation TMRM as a probe. The 
dependency of mitochondrial Δψ on MPTP formation was corroborated by our own result 
that the MPTP blocker CsA diminished significantly the changes in mitochondrial Δψ 
induced by tBOOH (Fig. 1, A); the difference between the changes in mitochondrial Δψ 
induced by tBOOH and the changes of this parameter in the presence of CsA can be thus 
regarded as a measure of MPTP formation. 
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The degree of LPO, as measured by MDA content, was dramatically increased by 
tBOOH, and the MPTP blocker CsA inhibited partially this effect (Fig. 1, B); a similar 
phenomenon had been reported elsewhere using the OS-sensitive fluorescent dye 
dichlorofluorescein as a probe to assess ROS generation (Nieminen 1997). This support the 
contention that tBOOH capability to induce ROS depends not only on the generation of 
peroxyl- and alkoxyl-free radicals after metabolization (Davies 1989) but also on its 
capability to induce MPTP formation. This CsA-sensitive fraction of tBOOH-induced LPO 
provides an observational window where the influence of signaling modulators on OS from 
mitochondrial origin can be monitored. 
As can be also seen in Fig. 1 A and B, the intracellular Ca
2+
-sequestering agent 
BAPTA/AM attenuated tBOOH-induced both mitochondrial depolarization and LPO to a 
similar extent to CsA. Overall, these results indicate that tBOOH-induced LPO depends 
partially on MPTP generation, and that this effect is facilitated by intracellular Ca
2+
 
elevations. 
In an attempt to find it out possible mediators of the facilitating effect of Ca
2+
 on 
MPTP formation and the further generation of mitochondrial ROS, we assessed the 
involvement of CaM and two of its putative downstream mediators, CaMKII and 
calcineurin, in the capability of tBOOH to induce MPT and LPO of mitochondrial origin. 
As shown in Fig. 1 A and B, respectively, the CaM antagonists TFP and W7 prevented 
completely the CsA-sensitive changes in mitochondrial Δψ and MDA content induced by 
tBOOH; CsA effect was not additive with that of W7, strongly suggesting that both the 
MPTP blocker and the CaM inhibitor acts via a similar mechanism, i.e. inhibition of MPTP 
formation. Similarly to the CaM inhibitors, the specific CaMKII inhibitor KN-62, but not 
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the calcineurin inhibitor FK-506 (tacrolimus), fully prevented both alterations. This 
indicates that both the onset of MPTP induced by tBOOH and the resulting oxidative stress 
from mitochondrial origin are modulated by CaM, via CaMKII activation. 
 
Effect of tBOOH on CaMKII activation. Western blot analysis of phosphorylated CaMKII 
showed that the amount of the phosphorylated, active form of CaMKII significantly 
increased at 15 min after tBOOH administration (Fig. 2). On the other hand, total CaMKII 
content remained unchanged. Pretreatment with the CaM inhibitors TFP and W7, or with 
the CaMKII inhibitor KN-62, completely prevented the increase in phosphorylated 
CaMKII. This rules out the alternative possibility that CaMKII is activated by direct 
oxidation of paired methionine residues in the regulatory domain of CaMKII in the absence 
of Ca
2+
/CaM, as was shown to occur in cardiomyocytes (Erickson 2008). 
 
Effect of tBOOH on JNK1/2 and p38
MAPK
 activation. Western blot analysis of 
phosphorylated and total forms of JNK1/2 and p38 MAPK showed that the amount of the 
phosphorylated, active form of these MAPKs significantly increased at 15 min of tBOOH 
administration, whereas total JNK1/2 and p38
MAPK
 content remained unchanged (Fig. 3). 
Pretreatment with the Ca
2+
-chelating agent BAPTA/AM, the CaM inhibitors TFP and W7, 
or with the CaMKII inhibitor KN-62 completely prevented the increase in phosphorylated 
JNK1/2 and p38
MAPK
. 
 
tBOOH induces apoptosis via the Ca
2+
/CaM/CaMKII signaling pathway. Because 
dissipation of the mitochondrial potential is a common and early feature of apoptosis, we 
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analyzed here whether tBOOH exposure leads to apoptosis, and whether inhibition of the 
Ca
2+
/CaM/CaMKII signaling pathway at different steps prevents this effect. Cytometric 
annexin V/propidium iodide assay showed that tBOOH significantly increased annexin V 
(+) /propidium iodide (-) cells (early apoptosis) by 86% (Fig. 4, A). The proportion of 
annexin V (+)/propidium iodide (+) (late apoptosis) also was increased by 122% (Fig. 4, B). 
As a consequence, the proportion of cells with either early or late apoptosis, i.e., annexin V 
(+) cells, was increased by 89% by tBOOH (Fig. 5, C). On the other hand, in cell pretreated 
with inhibitors acting at different levels in the Ca
2+
/CaM/CaMKII signaling pathway, the 
proportion of cells with either early apoptosis or late apoptosis after tBOOH exposure was 
similar to that of control cells, or to that treated with the MPTP blocker CsA (Fig. 4, A and 
B, respectively). A similar pattern of prevention was obtained when the proportion of 
apoptotic cells irrespective of their stage was considered (Fig. 4, C). 
 
Involvement of the mitochondrial pathway in tBOOH-induced apoptosis. The role for 
mitochondria in tBOOH-induced apoptosis via the Ca
2+
/CaM/CaMKII signaling pathway 
was assessed by studying the release of mitochondrial cytochrome c into cytosol, the 
further increase in the activity of caspase-3, and the balance between the mitochondrial pro-
apoptotic protein Bax and the anti-apoptotic protein Bcl-xL. 
Immunoblot analysis of cytosolic cytochrome c showed that there was an increase of 
120% in cytochrome c release from mitochondria after tBOOH exposure, and that Ca
2+
 
sequestration with BAPTA, inhibition of CaM with TFP or W7, and CaMKII inhibition 
with KN-62 all fully prevented mitochondrial cytochrome c release (Fig. 5). 
As anticipated from the fact that cytosolic cytochrome c triggers apoptosis via 
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activation of the executioner caspase-3, the activity of this caspase increased aprox. 3 times 
in cytosol after tBOOH exposure. This effect was also fully prevented by the MPTP 
blocker CsA, indicating that the “intrinsic” (mitochondrion-driven) pathway of caspase-3 
activation is triggered by tBOOH (Fig. 6). Ca
2+
 sequestration with BAPTA, inhibition of 
CaM with TFP or W7, and CaMKII inhibition with KN-62 all fully prevented the increase 
in caspase-3 activity at the same extent as CsA did. 
Finally, we examined the expression of Bax and Bcl-xL at the protein level in the 
mitochondrial fraction by western blot analysis. Bax and Bcl-xL are members of the Bcl-2 
family which plays major, opposite roles as regulators of the apoptotic process: while Bax 
acts as a promoter, Bcl-xL acts as an inhibitor (Tzung 1997). Immunoblot analyses revealed 
that mitochondrial Bax protein levels increased by 139% (P < 0.01) after tBOOH 
administration, whereas Bcl-xL remained virtually unchanged (Fig. 7, upper panel). 
Consequently, Bax-to-Bcl-xL ratio, an indicator of cell vulnerability to apoptosis, was 
increased by 186% by tBOOH (Fig. 7, lower panel). Inhibition of CaM with TFP or W7, 
and inhibition of CaMKII with KN-62 both prevented the increase in both Bax 
mitochondrial level and Bax-to-Bcl-xL ratio. 
 
Involvement of mitochondrial CaMKII in tBOOH-induced MPTP. CaMKII is a 
ubiquitous enzyme, and CaMKII with mitochondrial localization has been recently reported 
to play a crucial role in Ca
2+
-induced MPTP and apoptosis in cardiomyocytes (Joiner 
2012). To assess the involvement of mitochondrion-localized CaMKII in tBOOH-induced 
MPTP formation in hepatocytes, we studied in isolated hepatocellular mitochondria the 
effect CaMKII on tBOOH-induced osmotic swelling of the mitochondrial matrix, a 
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phenomenon due to opening of MPTPs in the inner mitochondrial membrane. The time 
course of mitochondrial swelling, as monitored by recording the decrease in absorbance 
(light-scattering) at 540 nm over 15 min, is shown in Fig. 8. Control mitochondria treated 
with the tBOOH vehicle showed a slight decrease due to spontaneous swelling, whose 
magnitude agrees with results obtained by others (Roy 2009; Lee 2008). On the other hand, 
tBOOH induced a fast decrease in light scattering due to MPTP formation, as confirmed by 
the fact that the MPTP blocker CsA fully abrogated this effect. Swelling was less 
pronounced when either the CaM inhibitor W7 or the CaMKII inhibitor KN-62 was present 
in the medium, suggesting a partial role for a mitochondrial Ca
2+
/CaM/CaMKII signalling 
pathway in tBOOH-mediated effect. 
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DISCUSSION 
 
MPTP onset has been implicated as a pivotal event contributing to hepatocyte cell 
death under OS conditions. This was readily apparent from studies showing that MPTP 
blockers inhibit the late phase of mitochondrial pyridine nucleotide oxidation and ROS 
generation in isolated hepatocytes exposed to tBOOH (Nieminen 1997). The MPTPs 
generated by an initial oxidant insult (ROS generated from tBOOH metabolization, in our 
case) further exacerbate ROS production by inducing leakage of electrons from the 
mitochondrial respiratory chain, which triggers a detrimental vicious circle (Nieminen 
1995). 
Despite there is compelling evidence in the literature that Ca
2+
 is involved in MPTP 
onset caused by oxidizing agents in hepatocytes (Imberti 1993; Byrne 1999), the 
intracellular events mediating this effect has not been fully clarified as yet; its elucidation is 
however relevant to develop new therapeutic approaches for protection against OS-induced 
hepatocellular damage. In this report, we provide novel evidence that the 
Ca
2+
/CaM/CaMKII signaling pathway plays a pivotal role in both tBOOH-induced MPTP 
formation in hepatocytes and its potential to exacerbate OS from mitochondiral origin, two 
events that are linked causally with each other. This is supported by our finding that Ca
2+
 
sequestration with BAPTA, blockage of the formation of the Ca
2+
/CaM complex with W7 
or TFP, or inhibition of CaMKII with KN-62 all prevented tBOOH-induced OS and MPTP 
formation to a similar extent to the MPTP blocker CsA (see Fig. 1). Our finding that no 
additive effect was recorded when both MPTP and CaM were simultaneously inhibited by 
CsA and W7, respectively (see Fig. 1), further confirms the involvement of MPTP as a 
common target of both inhibitors. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
25 
 
Disruption of intracellular Ca
2+
 homeostasis and defects in mitochondrial function 
induce cell death in a variety of pathological conditions involving Ca
2+
 elevations and 
oxidative damage [for reviews, see (Orrenius 1992; Lemasters 2009)]. Several lines of 
evidence indicate that many of these detrimental effects are mediated by CaM and/or 
CaMKII. For example, CaM and CaMKII inhibitors protect against both 
hypoxia/hypoglycemia- (Hajimohammadreza 1995) and veratridine-induced neuronal 
depolarization (Takano 2003). In addition, CaM antagonists attenuate MPTP-mediated 
neuronal death due to ischemia (Kuroda 1997), and apoptotic death of pheochromocytoma 
cells (PC12) induced by the depolarizing agent 1-methyl-4-phenylpyridinium (Lee 2005). 
In the latter cell line, ROS formation, cytochrome c release, activation of caspase-3 and cell 
death induced by rotenone, an inhibitor of mitochondrial-respiratory-chain-complex I, was 
counteracted by CaM antagonists. Similarly, CaM antagonists protected rat heart 
myocardium H9c2 cells against toxicity of rotenone by suppressing ROS formation 
(Yaglom 2003). Moreover, in rat ventricular, permeabilized cardiomyocytes, direct CaM 
exposure induced depolarization of Δψ mitochondrial and opening of MPTP by increasing 
ROS production in a CaMKII-dependent manner (Odagiri 2009) Finally, CaMKII has been 
implied in cadmiun-induced apoptosis in mesangial cells (Liu 2007). 
The role of Ca
2+
/CaM/CaMKII signaling pathway in MPTP opening and the 
associated generation of OS from mitochondrial origin had not been assessed in 
hepatocytes. Only some reports provides circumstantial evidence that CaM and/or CaMKII 
are involved in ROS generation and OS-induced liver damage, such as that induced by the 
hepatotoxicants acetaminophen (Dimova 1995) and CCl4 (Villarruel 1990). However, the 
action mechanisms of these toxic compounds are multifactorial in nature, and this prevents 
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a clear conclusion to be drawn on the CaM and/or CaMKII mechanisms of action. In this 
work, we provide mechanistic support for these preliminary results by showing that CaM 
modulates OS from mitochondrial origin via MPTP formation and further apoptotic 
hepatocellular death, and that this effect involves CaMKII as a main downstream effector. 
CaMKII belongs to the multifunctional, Ca
2+
/CaM-activated, serine/threonine kinase 
family (Hudmon 2002). Therefore, CaMKII may influence MPTP onset by modifying the 
phosphorylation status of mitochondrial proteins belonging to, or regulating, MPTP. In line 
with this, changes in the phosphorylation status of several low-molecular-weight, 
mitochondrial proteins were observed in rat brain associated with MPTP opening. 
Interestingly, this phenomenon was dependent on Ca
2+
, and prevented by the CaM 
antagonist calmidazolium (Azarashvili 2003). 
It is difficult at this stage to identify specific putative structural or regulatory 
components of the MPTP as target for CaMKII-mediated phosphorylation. To the best of 
our knowledge, only VDAC has been described to be regulated by different kinases, such 
as PKA (Bera 2001) and PKC (Baines 2003), but all these phosphorylations inhibited 
rather than enhanced MPTP opening probability. Finally, the “novel” PKC isoform PKC 
travels to mitochondria under OS conditions, where it triggers the release of cytochrome c 
and apoptosis (Horbinski 2005; Majumder 2001). However, this member of the “novel” 
PKC family is unresponsive to Ca
2+
. Alternatively, the “conventional”, Ca
2+
-dependent 
PKC isoform PKC, which we had showed to be activated by tBOOH in a previous work 
even at lower concentrations (100 µM) (Perez 2006), has prosurvival rather than 
proapoptotic functions in several cell lines (Horbinski 2005; Ruvolo 1998). Lack of 
involvement of all these PKC isoforms was further confirmed by our results that neither 
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phorbol-12-myristate 13-acetate nor staurosporine, which activates and inhibits both 
“conventional” and “novel” PKC isoforms, respectively (Gschwendt 1996), modified 
tBOOH capability to induce ROS generation, MPTP onset and apoptosis (data not shown). 
Rather, our results are more consistent with the existence of signaling cascades 
downstream of CaMKII involving JNK and p38
MAPK
 (see Fig. 3). This finding is in line 
with previous results showing that CaMKII can phosphorylate and activate both p38
MAPK
 
(Nguyen 2004) and JNK1/2 (Brnjic 2010), and that this event leads to apoptosis via 
activation of the upstream protein apoptosis signal-regulating kinase 1 (ASK1) (Brnjic 
2010; Liu 2013). A rol for these MAPKs in tBOOH-induced MPTP opening by 
phosphorylating apoptosis-related mitochondrial proteins is indeed likely. p38
MAPK
 
phosphorylates VDAC in myocardiocytes after myocardial isquemia reperfusion, and the 
kinase inhibition counteracted necrosis induced by this manoeuvre (Schwertz 2007); 
unfortunately, MPTP generation was not assessed under this condition. As for JNK, its 
activation has been shown to trigger Bax translocation to mitochondria by phosphorylation 
of the Bax cytosolic anchor protein 14-3-3 (Tsuruta 2004); this may explain our finding that 
mitochondrial Bax content increases after tBOOH exposure in a Ca
2+
/CaM/CaMKII-
dependent manner (see Fig. 7). Once in mitochondria, Bax oligomerizes in the outer 
mitochondrial membrane to form pores, which allows for cytochrome c release and further 
caspase-3 activation (Orrenius 2007), two events that have been also shown to occur here 
after tBOOH exposure in a Ca
2+
/CaM/CaMKII-dependent manner (see Figs. 5 and 6, 
respectively). The alternative possibility that JNK regulates Bax by direct phosphorylation 
is also likely. In the human hepatoma cell line HepG2, various cell death agonists, 
including pro-oxidant ones, induced apoptosis by promoting mitochondrial Bax 
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translocation via its phosphorylation at Thr
167
 by both JNK and p38
MAPK
 (Kim 2006). 
Whether activation of these kinases explains the dependency of tBOOH-induced apoptosis 
on CaMKII activity remains to be ascertained, and this is the subject of ongoing research. 
The possibility is likely, since CaMKII-dependent activation of JNK has been demonstrated 
to occur in other cellular models leading to mitochondrion-driven apoptosis (Timmins 
2009; Li 2012). 
Alternatively, CaMKII may upregulate by phosphorylation the activity of a 
phosphatase able to activate by dephosphorylation the effects of pro-apoptotic proteins 
known to be inhibited the phosphorylating activity of other protein kinases. For example, 
calcineurin, a Ca
2+
/CaM-dependent, serine-threonine phosphatase, induces apoptosis by 
promoting Bad dephosphorylation (Wang 1999). However, we were unable to abrogate 
tBOOH-induced both LPO and changes in mitochondrial Δψ by pre-treating hepatocytes 
with FK506, a specific calcineurin inhibitor (see Fig. 1). Incidentally, the lack of effect of 
FK506 confirms that the protective effect of CsA reported here was not due to its well-
establish inhibitory effect on calcineurin phosphatase activity (Hemenway 1999), but to its 
capability to abrogate MPTP onset (Bernardi 1996). 
Another possibility, which may well act in concert with the previous ones, is that 
CaMKII increases primarily mitochondrial Ca
2+
 uptake, and that the increase in 
mitochondrial Ca
2+
 helps per se to trigger MPTP opening by potentiating the capability of 
ROS to onset MPTP (Byrne 1999; Vercesi 2006). In line with this, a tight temporal 
correlation has been shown to exist between the increase in mitochondrial Ca
2+
 levels 
induced by tBOOH and the opening of MPTPs in primary cultured hepatocytes (Byrne 
1999). This holds true for other cell lines as well. In permeabilized rat ventricular 
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myocytes, exogenously added CaM opens MPTPs in a CaMKII-dependent manner, and this 
effect was causally related to the uptake of Ca
2+
 released from sarcoplasmic reticulum by 
neighboring mitochondria (Odagiri 2009). Complementarily, CaMKII mediates increase in 
Ca
2+
 entry through the inner membrane of the cardiomyocytes mitochondria via the 
mitochondrial Ca
2+
 uniporter (Joiner 2012). Furthermore, exogenously administered CaM 
stimulated ROS production in the mitochondrial matrix of cardiomyocytes in part via 
MPTP formation (Odagiri 2009). Recent studies by another group demonstrated that 
mitochondrial rather than cytosolic CaMKII isoform is involved in CaM capability to open 
MPTPs in this cell type, since mitochondrial targeting of a CaMKII inhibitor fully 
abrogated this effect (Joiner 2012). However, our results in hepatocyte isolated 
mitochondria showing that the CaM inhibitor W7 and the CaMKII antagonist KN-62 
inhibited tBOOH-induced MPTP formation only partially (see Fig. 8) suggest that cytosol-
localized CaMKII cooperates with the mitochondrial one to account for the full mediation 
of this enzyme in the MPTP opening recorded in intact hepatocytes (see Fig. 1). 
Another important Ca
2+
-mediated intramitochondrial mechanism involved in tBOOH-
mediated MPTP formation is the activation of the Ca
2+
-dependent cysteine protease 
calpain. Selective inhibition of this protease was shown to fully abrogate tBOOH-induced 
MPTP onset in isolated rat mitochondria (Aguilar 1996); the absolute dependency of MPTP 
formation on calpain activity suggests that CaMKII and calpain act through a common 
mechanism to onset MPTP. There is some circumstantial evidence in the literature that 
CaMKII can phopshorylate and activate calpain, as has been shown for calpain II isolated 
from vascular smooth muscle (McClelland 1994). The reverse activation sequence also may 
occur, since calpain I, like other proteases including caspases, activates in vitro 
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autophosphorylated CaMKII by proteolysis (Rich 1990). Whether this mutual activation 
applies to mitochondrial calpain isoform/s remains to be ascertained. Alternatively, 
CaMKII-mediated phosphorylation of a protein involved in MPTP formation may sensitize 
this substrate for further calpain-dependent proteolysis, as was described for the calpain-
induced proteolytic cleavage of GluR1 C-terminal fusion protein in cortical neurons (Yuen 
2007). Irrespective of the mechanism involved, a similar common dependency on CaMKII 
and calpain activity to produce cell death has been identified in another apoptosis model in 
hepatocytes, such as that induced by the protein phosphatase inhibitor microcystin (Ding 
2002). Actually, the tBOOH pro-apoptotic mechanisms revealed here strongly resembles 
those of microcystin in hepatocyes. In the case of microcystin, CaMKII is activated before 
ROS formation via inhibition of its dephosphorylation, and activated CaMKII mediates 
ROS mitochondrial formation via MPTP opening and further cytochrome c release, which 
triggers the execution of apoptosis (Ding 2003). Our results here showing that a similar 
mechanism applies for a “pure” model of OS strongly contributes to extrapolate this 
concept to other pro-oxidant hepatotoxicants, and to the several pathological situations 
involving OS as a cause of apoptotic hepatocellular death. 
In summary, as schematized in Fig. 9, our study shows that the Ca
2+
/CaM/CaMKII 
pathway plays a major role in tBOOH-induced MPTP formation, and the consequent 
exacerbation of both ROS formation from mitochondrial origin and hepatocellular 
apoptosis. This points CaM and CaMKII as promising targets for the development of new 
therapies to conteract hepatocellular oxidative damage. 
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Table 1 
Effect of tBOOH on cellular integrity, redox status and Ca
2+
 levels 
 DMSO 
a
 tBOOH
b
 
Cellular viability (% of total cells) 96 ± 3 62 ± 3* 
LDH release (% of total cell content) 32 ± 2 42 ± 3* 
ATP cellular content (µmol/10
6
 cells) 48 ± 6 43 ± 3 
MDA cellular content /nmol/mg prot.) 1.3 ± 0,2 8,0 ± 0,3* 
Total glutathione (mg/mg of protein) 27 ± 2 17 ± 1* 
GSSG-to-total glutathione ratio (%) 3,1 ± 0,1 4,1 ± 0,2* 
Cytosolic free Ca
2+
 (nM) 119 ± 11 3029 ± 474* 
Cells were pretreated for 15 min either with tBOOH (500 µM) or DMSO (controls). 
Note: LDH, lactate dehydrogenase; ATP, adenosine triphosphate; MDA, 
malondialdehyde; GSSG, oxidized glutathione. 
* p < 0.05 vs. DMSO, for n = 4-10. 
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FIGURE LEGENDS 
 
Figure 1. Involvement of Ca
2+
and signalling molecules acting downstream of Ca
2+
in 
tBOOH-induced mitochondrial permeability transition (MPT), and the subsequent 
malondialdehyde (MDA) formation. (A) Effect of the intracellular Ca
2+
 chelator 
BAPTA/AM (50 µM), the antagonists of CaM trifluoperazine (TFP, 10 µM) and W7 (100 
µM; with or without 5 µM cyclosporin A-CsA), the calcineurin inhibitor FK-506 (1 µM), 
or the CaMKII inhibitor KN-62 (10 µM) on tBOOH (500 µM, 15 min)-induced MPT, as 
assessed by measuring mitochondrial membrane depolarization as a surrogate marker, 
using tetra-methyl-rhodamine methyl ester as a fluorescent probe. Mitochondrial membrane 
depolarization was expressed as the percentage of the change in mitochondrial 
depolarization, in a scale ranging from a basal, non-depolarized condition (control value) to 
the maximal depolarized condition, obtained by adding the respiratory chain uncoupling 
compound, carbonyl cyanide m-chloro-phenylhydrazone (10 µM). The dotted line 
represents the mean value of the change in mitochondrial Δψ induced by tBOOH in 
hepatocytes pretreated with the MPTP blocker CsA (54 ± 3%); the differences of the values 
of the different experimental groups with this reference value reflects MPT-dependent 
changes in mitochondrial Δψ. (B) Effect of these pre-treatments on tBOOH-induced LPO, 
as evaluated by measuring MDA formation. The dotted line represents the mean value of 
the MDA content in CsA-pretreated hepatocytes exposed to tBOOH (54 ± 3%); the 
differences of the values of the different experimental groups with this reference value 
reflects MPT-dependent MDA formation. 
Note that BAPTA, the CaM antagonists and the CaMKII inhibitor prevented partially both 
MPTP and MDA formation to the same extent as the MPT blocker CsA did, suggesting that 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
41 
 
MPTP formation and the subsequent LPO are facilitated by Ca
+2
 elevations, and this 
phenomena are modulated by CaM via CaMKII activation. Contrarily, the calcineurin 
inhibitor FK-506 was without effect, suggesting that calcineurin play no role in tBOOH 
effects. 
Values are mean ± SE, for 4-10 independent experiments. 
a
Significantly different from 
control (p < 0 .05); 
b
significantly different from tBOOH-treated cells (p < 0.05). 
 
Figure 2. Activation by phosphorylation of CaMKII by tBOOH, and its prevention by CaM 
and CaMKII inhibition. Upper panel: Representative Western blottings of phospho (p)-
CaMKII and total CaMKII content in whole cellular lysates of cultured rat hepatocytes, 
exposed to tBOOH (500 µM, 15 min), with or without a 15-min pre-treatment with the 
CaM antagonists trifluorperazine (TFP, 10 µM) and W7 (100 µM), or with the CaMKII 
inhibitor KN-62 (10 µM). Lower panel: CaMKII phosphorylation status for each 
experimental condition, expressed as the phosphorylated-to-total CaMKII ratio, and 
referred to control values. Results are mean ± SE, for 5 independent experiments. 
a
Significantly different from control (p < 0.05); 
b
significantly different from tBOOH-treated 
cells (p < 0.05). 
 
Figure 3. Activation by phosphorylation of JNK1/2 and p38
MAPK
 by tBOOH, and its 
prevention by intracellular Ca
2+
 chelation and CaM/CaMKII inhibition. Upper panels: 
Representative Western blottings of (A) phospho (p)-JNK1/2 and (B) p-p38 MAPK, and of 
the total content of these MAPK in whole lysates of cultured rat hepatocytes, exposed to 
tBOOH (500 µM, 15 min), with or without a 15-min pre-treatment with the Ca
2+
 chelating 
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agent BAPTA/AM (50 µM), the CaM antagonists trifluorperazine (TFP, 10 µM) and W7 
(100 µM), or the CaMKII inhibitor KN-62 (10 µM). Lower panels: JNK1/2 and p38
MAPK
 
phosphorylation status for each experimental condition, expressed as the phosphorylated-
to-total ratio, and referred to control values. Results are mean ± SE, for 4 independent 
experiments. 
a
Significantly different from control (p < 0 .05); 
b
significantly different from 
tBOOH-treated cells (p < 0.05). 
 
Figure 4. Involvement of the Ca2+/CaM/CaMKII signaling pathway in tBOOH-induced 
apoptosis. Apoptosis was assessed with annexin V-FITC and propidium iodide (PI) 
staining, by using flow cytometry analysis. Cells in culture were incubated with tBOOH 
(500 µM, 15 min), with or without a 15-min pre-treatment with the mitochondrial 
permeability transtion blocker cyclosporin A (CsA, 5 µM), the intracellular Ca
2+
 chelator 
BAPTA/AM (50 µM), the CaM antagonists trifluorperazine (TFP, 10 µM) and W7 (100 
µM), or the CaMKII inhibitor KN-62 (10 µM). The percentages of cells (referred to control 
values) with early apoptosis [annexin V (+)/PI (-)], with late apoptosis [annexin V (+)/PI 
(+)], or with any stage of apoptosis [annexin V (+)], are depicted in the panels A, B, and C, 
respectively. Results represent mean ± SEM of 3 experiments. 
a
Significantly different from 
control (p < 0 .05); 
b
significantly different from tBOOH-treated cells (p < 0.05). 
 
Figure 5. Involvement of the Ca2+/CaM/CaMKII signaling pathway in tBOOH-induced 
mitochondrial release of cytochrome c. Upper panel: Representative Western blottings of 
cytochrome c content in the cytosolic fraction of cultured rat hepatocytes exposed to 
tBOOH (500 µM, 15 min), with or without a 15-min pre-treatment with the CaM antagonist 
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W7 (100 µM), or with the CaMKII inhibitor KN-62 (10 µM); ß-actin was used as loading 
control. Lower panel: Densitometric analysis of cytochrome c electrophorectic bands for 
each experimental condition, referred to the respective signal intensity of ß-actin, and 
expressed as percentage of control values. Data are mean ± SE for 5 separate experiments. 
a
Significantly different from control (p < 0 .05); 
b
significantly different from tBOOH-
treated cells (p < 0.05). 
 
Figure 6. Involvement of the Ca2+/CaM/CaMKII signaling pathway in tBOOH-induced 
activation of caspase-3. Activity of caspase-3 in cultured cells exposed to tBOOH (500 
µM, 15 min), with or without a 15-min pre-treatment with the mitochondrial permeability 
transtion blocker cyclosporin A (CsA, 5 µM), the intracellular Ca
2+
 chelator BAPTA/AM 
(50 µM), the CaM antagonists trifluorperazine (TFP, 10 µM) and W7 (100 µM), or the 
CaMKII inhibitor KN-62 (10 µM). Caspase-3 activity was determined by using a 
fluorometric assay, as described in Material and Methods Section. Bars represent activity 
expressed as percentage of control values. Data are mean ± SE for 4 independent 
experiments. 
a
Significantly different from control group (p < 0 .05); 
b
significantly different 
from tBOOH-treated cells (p < 0.05). 
 
Figure 7. Involvement of the Ca2+/CaM/CaMKII signaling pathway in tBOOH-induced 
increase in the Bax-to-Bcl-xL ratio. Upper panel: Representative Western blottings of Bax 
and Bcl-xL illustrating their protein expressions in the mitochondrial fraction of cultured rat 
hepatocytes exposed to tBOOH (500 µM, 15 min), with or without a 15-min pre-treatment 
with the CaM antagonist W7 (100 µM), or the CaMKII inhibitor KN-62 (10 µM); 
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prohibitin was used as a mitochondrial protein loading control. Lower panel: Bax-to-Bcl-
xL ratio for each experimental condition, calculated from the densitometric analysis of the 
electrophorectic bands of these proteins normalized to the respective signal intensity of 
prohibitin, and expressed as percentage of controls. Data are mean ± SE for 3 independent 
experiments. 
a
Significantly different from control group (p < 0 .05); 
b
significantly different 
from tBOOH-treated cells (p < 0.05). 
 
Figure 8. Effect of CaM and CaMKII antagonists on tBOOH-induced swelling of isolated 
rat liver mitochondria. Mitochondria were suspended at a concentration of 0.5 mg of 
protein/ml, and a 2-min baseline of light scattering at 540 nm was obtained. Then, tBOOH 
(500 μM final concentration) was added to the swelling buffer, together (or not) with the 
mitochondrial permeability transtion blocker cyclosporin A (CsA, 5 µM), the CaM 
antagonist W7 (100 µM), or the CaMKII inhibitor KN-62 (10 µM). Changes in light 
scattering at 540 nm were then recorded at 30-s intervals for 15 min. Data are mean ± SE 
for 8-16 independent experiments. *p < 0 .005; 
#
p < 0.001. 
 
Figure 9. Schematic representation of the main conslusions drawn from this study. The 
Ca
2+
-calmodulin (CaM)-dependent protein kinase type II (CaMKII) signaling pathway 
mediates the facilitating role of oxidative-stress-induced Ca
2+
 mitochondrial permeability 
transition via both the onset of the mitochondrial permeability transition pore (MPTP), 
probably via p38
MAPK
 (p38) activation, and Bax translocation to mitochondria, probably via 
JNK activation. Disruption of the mitochondrial permeability barrier leads to: a) 
impairment of the mitochondrial electron transport chain with leakage of electrons and 
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subsequent ROS generation from mitochondrial origin, which contributes to the 
amplification/perpetuation of the oxidative damage, and b) hepatocellular death by 
apoptosis via the mitochondrial pathway, due to the mitochondrial pore-mediated release of 
cytochrome c (Cyt c), followed by apoptosome formation and activation of caspase-3 
(Casp-3). 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Figure 1
Click here to download high resolution image
Figure 2
Click here to download high resolution image
Figure 3
Click here to download high resolution image
Figure 4
Click here to download high resolution image
Figure 5
Click here to download high resolution image
Figure 6
Click here to download high resolution image
Figure 7
Click here to download high resolution image
Figure 8
Click here to download high resolution image
Figure 9
Click here to download high resolution image
